Manama: The National Health Regulatory Authority (NHRA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET – PROTON 20mg E.C TABLET”, produced by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO). The move is based on the warning issued by the Saudi Food and Drug Authority (SFDA) on March 12, 2021. The NHRA indicated said that it has withdrawn the medicine from the Kingdom, and suspended its registration because it does not match the original product. The NHRA recommended the health authorities to withdraw the product as soon as it is available to them, calling on the medicine users to contact their doctors to receive the alternative medication.
Trending
- New York City under blizzard warning, travel ban as winter storm hits Northeast
- LMRA conducts 1,514 inspection campaigns and visits
- Industry Minister: Ministerial Decision (7) of 2026 prohibits single-use plastic bags less than 57 microns to promote sustainability
- HRH the Deputy chairs the weekly Cabinet Meeting
- At least 5 killed in a string of avalanches in western Austria
- China renews blue alert for cold wave, strong winds
- Germany Interior Minister plans to speed up asylum seeker work access
- Leclerc tops F1 pre-season testing in Bahrain
